Spotlight: August-October 2022

Words by Jade Williams

05 August

Sanofi and Innovent Biologics partner to expand access to innovative medicines for hard-to-treat cancers in China


11 August

Medicines Discovery Catapult and Zeiss collaborate to drive microscopy use in drug discovery


23 August

Roche launches PCR system with potential to find and quantify ultra-rare, hard-to-detect disease mutations


24 August

AbbVie and J&J’s drug Imbruvica for chronic graft-versus-host disease gains first paediatric approval from FDA


30 August

Neurocrine Biosciences acquires UK biotech Diurnal Group for £48.3m


06 September

WHO grants prequalification to GSK’s Mosquirix – the first and only approved malaria vaccine


07 September

Almylyx’s drug to slow ALS progression receives FDA recommendation after rejection in March


13 September

Merck Foundation launches $20m, five-year initiative to address inequities in cancer care in the US


21 September

GSK and Microsoft launch disease surveillance project in Nepal to tackle climate-based disease transmission


26 September

Moderna joins the UK Bioindustry Association as its 500th member


28 September

Eisai and Biogen’s lecanemab first Alzheimer’s drug to meet primary endpoints in Phase 3 trial


03 October

FDA approves Kite Pharma’s retroviral vector manufacturing facility in California for commercial production


This news round up will feature in GOLD 24 – subscribe now to read the full issue when it's published on 25 October.